Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options.
New York, NY (PRWEB) May 15, 2013
The medication resource center DrugRisks.com is announcing new information on the site for patients taking the blood thinner Pradaxa. A federal panel has disclosed that the amount of patients filing claims alleging internal bleeding from the drug has risen in recent months*.
DrugRisks was created to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.
Health experts have disagreed over whether Pradaxa has higher risks of internal bleeding than traditional anticoagulants. The FDA has stated the drug is as safe as warfarin**. The Institute for Safe Medication Practices, however, recently ranked drugs like Pradaxa among the most dangerous, and warned that Pradaxa bleeding may be nearly 5 times as likely to result in death than bleeding from warfarin or Coumadin***.
The resource center has also added a study from the University of Illinois at Chicago suggesting the data used by the FDA may be flawed, and the risk for Pradaxa bleeding may be higher than expected****.
With a growing number of patients filing a Pradaxa lawsuit alleging internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
Now, DrugRisks has learned that the latest figures from that court show the number of patient claims has grown from 260 on March 5th to 663 as of May 15th*.
Anyone affected by internal bleeding after taking Pradaxa is encouraged to speak with a lawyer about their legal options. Due to the specialized nature of federal drug injury cases, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.
Visit http://www.DrugRisks.com today for more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.
*Judicial Panel on MultiDistrict Litigation, 5/15/13; jpml.uscourts.gov/sites/jpml/files/Pending%20MDL%20Dockets_By%20District_May-14-2013.pdf
**FDA 11/2/12; http://www.fda.gov/Drugs/DrugSafety/ucm326580.htm
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****New England Journal of Medicine, 4/4/13; nejm.org/doi/full/10.1056/NEJMp1302834